Education
About Us
Working with TipRanks
Follow Us
MediPharm Labs (TSE:LABS)
TSX:LABS
Total Valuation
MediPharm Labs has a market cap or net worth of $29.06M. The enterprise value is C$20.74M.
Market Cap$29.06M
Enterprise ValueC$20.74M
Share Statistics
MediPharm Labs has 415,138,980 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding415,138,980
Owned by Insiders8.78%
Owned by Institutions―
Financial Efficiency
MediPharm Labs’s return on equity (ROE) is -0.25 and return on invested capital (ROIC) is -24.81%.
Return on Equity (ROE)-0.25
Return on Assets (ROA)-0.20
Return on Invested Capital (ROIC)-24.81%
Return on Capital Employed (ROCE)-0.25
Revenue Per Employee260.63K
Profits Per Employee-66.42K
Employee Count161
Asset Turnover0.78
Inventory Turnover3.35
Valuation Ratios
The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.
PE Ratio―
PS Ratio0.00
PB Ratio0.67
Price to Fair Value0.57
Price to FCF-4.46
Price to Operating Cash Flow-4.58
PEG Ratio-0.15
Income Statement
In the last 12 months, MediPharm Labs had revenue of 41.96M and earned -10.69M in profits. Earnings per share was -0.03.
Revenue41.96M
Gross Profit12.80M
Operating Income-10.81M
Pretax Income-10.69M
Net Income-10.69M
EBITDA-7.52M
Earnings Per Share (EPS)-0.03
Cash Flow
In the last 12 months, operating cash flow was -6.35M and capital expenditures -175.00K, giving a free cash flow of -6.52M billion.
Operating Cash Flow-6.35M
Free Cash Flow-6.52M
Free Cash Flow per Share-0.02
Dividends & Yields
MediPharm Labs pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.38
52-Week Price Change0.00%
50-Day Moving Average0.08
200-Day Moving Average0.08
Relative Strength Index (RSI)45.52
Average Volume (3m)175.47K
Important Dates
MediPharm Labs upcoming earnings date is Aug 18, 2025, TBA (Confirmed).
Last Earnings DateMay 14, 2025
Next Earnings DateAug 18, 2025
Ex-Dividend Date―
Financial Position
MediPharm Labs as a current ratio of 3.15, with Debt / Equity ratio of 0.29%
Current Ratio3.15
Quick Ratio2.32
Debt to Market Cap0.01
Net Debt to EBITDA1.50
Interest Coverage Ratio-18.77
Taxes
In the past 12 months, MediPharm Labs has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
MediPharm Labs EV to EBITDA ratio is -1.75, with an EV/FCF ratio of -2.63.
EV to Sales0.31
EV to EBITDA-1.75
EV to Free Cash Flow-2.63
EV to Operating Cash Flow-2.71
Balance Sheet
MediPharm Labs has $8.44M in cash and marketable securities with C$125.00K in debt, giving a net cash position of -$8.32M billion.
Cash & Marketable Securities$8.44M
Total DebtC$125.00K
Net Cash-$8.32M
Net Cash Per Share-$0.02
Tangible Book Value Per Share$0.10
Margins
Gross margin is 33.23%, with operating margin of -25.76%, and net profit margin of -25.49%.
Gross Margin33.23%
Operating Margin-25.76%
Pretax Margin-25.49%
Net Profit Margin-25.49%
EBITDA Margin-17.92%
EBIT Margin-24.11%
Analyst Forecast
The average price target for MediPharm Labs is ―, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target―
Price Target Upside―
Analyst ConsensusHold
Analyst Count0
Revenue Growth Forecast16.24%
EPS Growth Forecast46.47%